Vanguard disaggregates holdings; reports 0 shares of Argan Inc (AGX)
Rhea-AI Filing Summary
Argan Inc ownership disclosure: The Vanguard Group filed an Amendment No. 5 to Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Argan Inc common stock as disclosed in the amendment. The filing explains an internal realignment effective 01/12/2026 under SEC Release No. 34-39538 that led certain Vanguard subsidiaries and business divisions to report holdings separately.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal disaggregation.
The amendment states 0 shares and 0% ownership as of the filing and describes an internal realignment on 01/12/2026 relying on SEC Release No. 34-39538. This reflects a reporting change rather than a market transaction affecting Argan's share count.
Watch subsequent filings from Vanguard affiliates for any separate beneficial ownership reports that may disclose holdings previously aggregated under Vanguard.
Amendment clarifies reporting responsibilities under SEC guidance.
The filing cites SEC Release No. 34-39538 and states that subsidiaries/business divisions will report separately; this is a compliance-driven disaggregation of prior aggregated reporting. The signature block shows the form was signed on 03/26/2026.
Regulatory observers should note the amended filing reflects a change in reporting structure, not an assertion of ownership by the parent entity.
FAQ
What does Vanguard report for Argan Inc (AGX) ownership in this amendment?
Why did The Vanguard Group change its reporting for AGX holdings?
Does this amendment indicate Vanguard sold Argan Inc shares?
Who signed the Schedule 13G/A amendment for Vanguard and when?
Will other Vanguard entities report holdings for AGX separately now?